Skip Navigation



JAC Advance Access published online on July 15, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg340
© 2003 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/2/264    most recent
dkg340v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pagliano, P.
Right arrow Articles by Faella, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagliano, P.
Right arrow Articles by Faella, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The British Society for Antimicrobial Chemotherapy

Original article

Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001)

Pasquale Pagliano 1 *, Marco Rossi 1 , Carolina Rescigno 1 , Sergio Altieri 2 , Maria Grazia Coppola 2 , Marina Gramiccia 3 , Aldo Scalone 3 , Luigi Gradoni 3 , and Francesco Faella 1

1 I Division of Infectious Disease, D. Cotugno Hospital, Naples
2 Division of Parasitology, D. Cotugno Hospital, Naples
3 Department of Parasitology, Istituto Superiore di Sanità, Rome, Italy

* Corresponding author. E-mail: ppagliano{at}libero.it.

Received 5 February 2003 ; revised 3 April 2003 ; accepted 28 May 2003

Abstract

Aim: To evaluate in a retrospective analysis cases of Mediterranean visceral leishmaniasis (VL) diagnosed in HIV-negative adults during a 7-year period.

Materials and methods: Demographic data, previous or underlying diseases, clinical and laboratory features and therapeutic findings were considered.

Results: A total of 64 patients were included, of whom 10 (16%) had underlying diseases and two were pregnant. Fever and hepatosplenomegaly were the main presenting symptoms, whereas pancytopenia and an elevated erythrocyte sedimentation rate were observed in all cases. Smears from bone marrow aspirate were positive at microscopy in 62 cases (97%). Twenty-four patients received meglumine antimoniate (MA) given during 21 consecutive days (20 mg/kg per day), and 40 patients liposomal amphotericin B (l-AmB) given at days 1-5 and 10 (3 mg/kg per day). Both groups' clinical and laboratory findings improved, but patients on l-AmB therapy had a faster recovery (85% on l-AmB therapy and 50% on MA therapy showed defervescence at day 5, P < 0.01). Treatment failures were observed in five cases, three (12%) on MA and two (5%) on l-AmB therapy. No significant toxicity was observed in patients treated with l-AmB, whereas three (12%) patients treated with MA showed electrocardiographic abnormalities.

Conclusions: l-AmB therapy may be considered the treatment of choice for any adult patients with Mediterranean VL, since it permits a faster recovery, has a lower incidence of side effects and is useful also in immunosuppressed patients.

Keywords: visceral leishmaniasis, liposomal amphotericin B, meglumine antimoniate, Leishmania infantum, treatment
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
P. Pagliano, S. Costantini, L. Gradoni, F. S. Faella, A. Spasiano, G. Mascarella, L. Prossomariti, U. Fusco, and P. Ricchi
Distinguishing Visceral Leishmaniasis from Intolerance to Pegylated Interferon-{alpha} in a Thalassemic Splenectomized Patient Treated for Chronic Hepatitis C
Am J Trop Med Hyg, July 1, 2008; 79(1): 9 - 11.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
P. Pagliano, N. Carannante, M. Gramiccia, T. Ascione, G. Stornaiuolo, L. Gradoni, F. S Faella, and G. B Gaeta
Visceral leishmaniasis causes fever and decompensation in patients with cirrhosis
Gut, June 1, 2007; 56(6): 893 - 894.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. Bassetti, C. Pizzorni, L. Gradoni, V. Del Bono, M. Cutolo, and C. Viscoli
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab
Rheumatology, November 1, 2006; 45(11): 1446 - 1448.
[Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
G. Di Nicuolo, P. Pagliano, S. Battisti, M. Starace, V. Mininni, V. Attanasio, and F. S. Faella
Toscana Virus Central Nervous System Infections in Southern Italy
J. Clin. Microbiol., December 1, 2005; 43(12): 6186 - 6188.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. Pagliano, N. Carannante, M. Rossi, M. Gramiccia, L. Gradoni, F. S. Faella, and G. B. Gaeta
Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature
J. Antimicrob. Chemother., February 1, 2005; 55(2): 229 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
H. W. MURRAY
TREATMENT OF VISCERAL LEISHMANIASIS IN 2004
Am J Trop Med Hyg, December 1, 2004; 71(6): 787 - 794.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. Cascio, L. di Martino, P. Occorsio, R. Giacchino, S. Catania, A. R. Gigliotti, C. Aiassa, C. Iaria, S. Giordano, C. Colomba, et al.
A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience
J. Antimicrob. Chemother., July 1, 2004; 54(1): 217 - 220.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.